BENZYLAMINOCHINUCLIDINEN MIT EIN DURCH EIN HETERONOM SUBSTITUIERTES ALKYL ALS SUBSTANZ P ANTAGONISTE

PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24, 1994Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of the formula I and the pharm...

Full description

Saved in:
Bibliographic Details
Main Author SATAKE, KUNIO
Format Patent
LanguageGerman
Published 03.04.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24, 1994Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of the formula I and the pharmaceutically-acceptable salts thereof; (I) wherein R is C1-C6 alkyl; X is C1-C6 alkyl having one or more substituents which include at least one heteroatom; Ar1 and Ar2 are each, independently, aryl optionally substituted by one C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, halogen, cyano, nitro, phenoxy, mono C1-C6 alkylamino, di C1-C6 alkylamino, halosubstituted C1-C6 alkyl, or halosubstituted C1-C6 alkoxy; Y is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl, Z-(CH2)p-, or W-(CH2)m-CHR2-(CH2)n-NR1CO- wherein Y is at the 4-, 5- or 6-position on the quinuclidine ring; R1 is hydrogen, C1-C6 alkyl, benzyl or -(CH2)r-W; R2 is hydrogen or C1-C6 alkyl which may be substituted by one hydroxy, amino, methylthio, methylmercapto, benzyl, 4-hydroxybenzyl, 3-indolylmethyl or -(CH2)r-W; R1 may form a ring with R2; Z is C1-C6 alkoxy, -CONR4R5, -CO2R4, -CHR4OR5, -CHR4NR5R6, -COR4, -CONR4OR5 or optionally substituted aryl; each W is independently cyano, hydroxymethyl, C2-C6 alkoxymethyl, aminomethyl, mono C1-C6 alkylaminomethyl, di C1-C6 alkylaminomethyl, carboxyl, carbamoyl or C1-C6 alkoxycarbonyl; R4, R5 and R6 are independently hydrogen, C1-C6 alkyl, C1-C6 alkoxy, C3-C8 cycloalkyl or an optionally substituted aryl or heterocyclic group; p is 0 to 6; and m, n and r are each, independently, 0 to 3.
AbstractList PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24, 1994Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of the formula I and the pharmaceutically-acceptable salts thereof; (I) wherein R is C1-C6 alkyl; X is C1-C6 alkyl having one or more substituents which include at least one heteroatom; Ar1 and Ar2 are each, independently, aryl optionally substituted by one C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, halogen, cyano, nitro, phenoxy, mono C1-C6 alkylamino, di C1-C6 alkylamino, halosubstituted C1-C6 alkyl, or halosubstituted C1-C6 alkoxy; Y is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl, Z-(CH2)p-, or W-(CH2)m-CHR2-(CH2)n-NR1CO- wherein Y is at the 4-, 5- or 6-position on the quinuclidine ring; R1 is hydrogen, C1-C6 alkyl, benzyl or -(CH2)r-W; R2 is hydrogen or C1-C6 alkyl which may be substituted by one hydroxy, amino, methylthio, methylmercapto, benzyl, 4-hydroxybenzyl, 3-indolylmethyl or -(CH2)r-W; R1 may form a ring with R2; Z is C1-C6 alkoxy, -CONR4R5, -CO2R4, -CHR4OR5, -CHR4NR5R6, -COR4, -CONR4OR5 or optionally substituted aryl; each W is independently cyano, hydroxymethyl, C2-C6 alkoxymethyl, aminomethyl, mono C1-C6 alkylaminomethyl, di C1-C6 alkylaminomethyl, carboxyl, carbamoyl or C1-C6 alkoxycarbonyl; R4, R5 and R6 are independently hydrogen, C1-C6 alkyl, C1-C6 alkoxy, C3-C8 cycloalkyl or an optionally substituted aryl or heterocyclic group; p is 0 to 6; and m, n and r are each, independently, 0 to 3.
Author SATAKE, KUNIO
Author_xml – fullname: SATAKE, KUNIO
BookMark eNqNir0OgjAURjvo4N87NO4OiD9xLOVqbyy3hl4GWAjROhkgwfePRn0Al--c5HxTMWq7NkzELQGqSqsyJKcNUqEtpkhAMkOWgCTTItfmYwYYckcuk75IPCMXCDmDl8qeS_te_w2KKnmRilidHKFnmIvxvXkMYfHjTCyPwNqsQt_VYeiba2jDs05hd9jE0X4bMa_jv04vcpw3tg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID DE69431751TT2
GroupedDBID EVB
ID FETCH-epo_espacenet_DE69431751TT23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:26:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DE69431751TT23
Notes Application Number: DE19946031751T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030403&DB=EPODOC&CC=DE&NR=69431751T2
ParticipantIDs epo_espacenet_DE69431751TT2
PublicationCentury 2000
PublicationDate 20030403
PublicationDateYYYYMMDD 2003-04-03
PublicationDate_xml – month: 04
  year: 2003
  text: 20030403
  day: 03
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies PFIZER INC., NEW YORK
RelatedCompanies_xml – name: PFIZER INC., NEW YORK
Score 2.5700445
Snippet PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title BENZYLAMINOCHINUCLIDINEN MIT EIN DURCH EIN HETERONOM SUBSTITUIERTES ALKYL ALS SUBSTANZ P ANTAGONISTE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030403&DB=EPODOC&locale=&CC=DE&NR=69431751T2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1BT8IwFG4IGvWmqFFR0xizG5GxwdxhMVtbXHV0hHUGuBA2tkQPQGTGv-9bBfTEpWnapGmbvPd9X_tei9C9npfQMrMbVpZlIFAs8IP2VAeVYut5lreBZZS5wz3R8WPzZdgeVtDHJhdGvRP6rR5HBItKwd4L5a-Xf4dYVMVWrh6Sd2haPHWlQ7WNOgZx3jQ06jmsH9KQaIQ4lGli4HRshZS6BHe9BzTaKq2BvXllVsryP6R0j9F-H0abFyeoMstq6JBsfl6roYPe-sIbqmvbW52imcfEeBS4PS5C4nMRk4BTLpjA4H4w4wLTeEB8VfMZsNTyh0IcxV4kuYw5A-IaYTd4HQVQRr8drhjjPnaFdJ9DwSPJztBdl0niN2C6k-3eTCjbrky2jHNUnS_m2QXCrU5qWU3gNvY0MVPQWCkooyQ1zNR6BFjML1F9x0BXO3vr6EiFtJXxK8Y1qhafX9kNQHOR3Ko9_QFpeIru
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFG6IGvGmqFHxR2PMbkTGgLnDYra2uMroCOsMcCFsbIkegMiM_75vFdATl6Zpk6Zt8t73fe17LUIPelZAy8yqmWmagkAxwQ9aUx1UiqVnadYCllHkDvdE24uar8PWsIQ-Nrkw6p3Qb_U4IlhUAvaeK3-9_DvEoiq2cvUYv0PT4rkjbapt1DGI87qhUddm_YAGRCPEpkwTA7ttKaTUJbjrfaDYZmEN7M0tslKW_yGlc4wO-jDaPD9BpVlaQWWy-Xmtgg576wtvqK5tb3WKZi4T45Hv9LgIiMdFRHxOuWACg_vBjAtMowHxVM1jwFKLHwpxGLmh5DLiDIhriB2_O_KhDH87HDHGfewI6bwEgoeSnaH7DpPEq8F0J9u9mVC2XZlsGOdob76YpxcIN9qJadaB21jTuJmAxkpAGcWJ0UzMJ4DF7BJVdwx0tbP3DpU92fMnPhfdKjpS4W1FLItxjfbyz6_0BmA6j2_V_v4AGruN4Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BENZYLAMINOCHINUCLIDINEN+MIT+EIN+DURCH+EIN+HETERONOM+SUBSTITUIERTES+ALKYL+ALS+SUBSTANZ+P+ANTAGONISTE&rft.inventor=SATAKE%2C+KUNIO&rft.date=2003-04-03&rft.externalDBID=T2&rft.externalDocID=DE69431751TT2